Abstract:Background: The coronavirus disease 2019 (COVID-19) has become a worldwide pandemic since mid-December 2019, which greatly challenge public medical systems. With limited medical resources, it is a natural strategy, while adopted, to access the severity of patients then determine the treatment priority. However, our work observes the fact that the condition of many mild outpatients quickly worsens in a short time, i.e. deteriorate into severe/critical cases. Hence, it has been crucial to early identify those cases and give timely treatment for optimizing treatment strategy and reducing mortality. This study aims to establish an AI model to predict mild patients with potential malignant progression.Methods: A total of 133 consecutively mild COVID-19 patients at admission who was hospitalized in Wuhan Pulmonary Hospital from January 3 to February 13, 2020, were selected in this retrospective IRB-approved study. All mild patients at admission were categorized into groups with or without malignant progression. The clinical and laboratory data at admission, the first CT, and the follow-up CT at severe/critical stage of the two groups were compared with Chi-square test, Fisher's exact test, and t test. Both traditional logistic regression and deep learning-based methods were used to build the prediction models. The area under ROC curve (AUC) was used to evaluate the models.Findings: The deep learning-based method significantly outperformed logistic regression (AUC 0·954 vs. 0·893). The deep learning-based method achieved a prediction AUC of 0·938 by combining the clinical data and the CT data, significantly outperforming its counterpart trained with clinical data only by 0.141. By further considering the temporal information of the CT sequence, our model achieved the best AUC of 0·954.Interpretation: The proposed model can be effectively used for finding out the mild patients who are easy to deteriorate into severe/critical cases so that such patients get timely treatments while alleviating the limitations of medical resources.Funding Statement:This work was supported by National Key R&D Program of China (No. 2018YFB1004600), HUST COVID-19 Rapid Response Call (No. 2020kfyXGYJ093, No. 2020kfyXGYJ094), National Key R&D Program of China (No.2017YFC1309100), National Science Fund for Distinguished Young Scholars (No.81925023), National Natural Science Foundation of China (No.61703049, No. 81771912, No. 81401390)Declaration of Interests: The authors declare no competing interests.Ethics Approval Statement: The authors stated this was an IRB-approved study.

Developing deep LSTMs with later temporal attention for predicting COVID-19 severity, clinical outcome, and antibody level by screening serological indicators over time

Extracting Dynamic Information of Temporal Clinical Data to Predict the Outcome in Critically Ill Patients.

A prediction model based on machine learning for diagnosing the early COVID-19 patients

Predicting COVID-19 disease progression and patient outcomes based on temporal deep learning

Attention-Based LSTM Network for COVID-19 Clinical Trial Parsing

A predictive paradigm for COVID-19 prognosis based on the longitudinal measure of biomarkers

Deep learning for predicting COVID-19 malignant progression

Long Short-Term Memory Based Framework for Longitudinal Assessment of COVID-19 Using CT Imaging and Laboratory Data

Continual Deterioration Prediction for Hospitalized COVID-19 Patients

The emotion prediction of college students with attention LSTM during the COVID19 epidemic

An Interpretable Deep Learning Model for Predicting the Risk of Severe COVID-19 from Spike Protein Sequence

Statistical Analysis and Machine Learning Prediction of Disease Outcomes for COVID-19 and Pneumonia Patients

Predicting Outcomes in Long COVID Patients with Spatiotemporal Attention

A multistage multimodal deep learning model for disease severity assessment and early warnings of high-risk patients of COVID-19

Interpretable Machine Learning for COVID-19: An Empirical Study on Severity Prediction Task

Using Machine Learning Algorithms Based on Patient Admission Laboratory Parameters to Predict Adverse Outcomes in COVID-19 Patients

Long‐term SARS‐CoV‐2 neutralizing antibody level prediction using multimodal deep learning: A prospective cohort study on longitudinal data in Wuhan, China

Predicting COVID-19 Malignant Progression with AI Techniques

Temporal Deep Learning Architecture for Prediction of COVID-19 Cases in India

High-resolution short-term prediction of the COVID-19 epidemic based on spatial-temporal model modified by historical meteorological data